Copyright
©2012 Baishideng Publishing Group Co.
World J Cardiol. Jan 26, 2012; 4(1): 8-14
Published online Jan 26, 2012. doi: 10.4330/wjc.v4.i1.8
Published online Jan 26, 2012. doi: 10.4330/wjc.v4.i1.8
Patient | Age | Gender | CHA2DS2-VASC | HAS-BLED | Treatment at discharge | Follow up (mo) | Non-fatal events | Follow up (mo) | Survival |
1 | 87 | Female | 6 | 5 | Warfarin | 2 | None | 2 | Alive |
2 | 76 | Male | 4 | 4 | Aspirin | 32 | None | 32 | Alive |
3 | 81 | Female | 5 | 3 | Warfarin + Aspirin | 7 | None | 7 | Alive |
4 | 80 | Female | 4 | 3 | Warfarin | 1 | None | 1 | Alive |
5 | 90 | Female | 6 | 2 | Warfarin | 26 | None | 26 | Alive |
6 | 77 | Female | 5 | 3 | Warfarin | 23 | None | 23 | Alive |
7 | 68 | Female | 2 | 2 | Aspirin + Clopidogrel | 10 | None | 10 | Alive |
8 | 83 | Male | 7 | 4 | Warfarin + Aspirin | 3 | None | 3 | Death, non-cardiac |
9 | 80 | Female | 3 | 2 | Warfarin | 19 | None | 19 | Alive |
10 | 79 | Female | 5 | 3 | Warfarin + Aspirin | 30 | Stroke | 31 | Death, non-cardiac |
11 | 84 | Female | 5 | 3 | Warfarin + Clopidogrel | 1 | Heart failure admission | 31 | Alive |
12 | 87 | Female | 4 | 2 | Warfarin + Aspirin | 6 | None | 6 | Alive |
13 | 83 | Female | 3 | 2 | Warfarin | 5 | None | 5 | Alive |
14 | 82 | Male | 3 | 3 | Warfarin + Aspirin | 2 | None | 2 | None |
15 | 68 | Male | 3 | 2 | Warfarin + Clopidogrel | 1 | Heart failure admission | 3 | Alive |
- Citation: Salinas P, Moreno R, Calvo L, Jiménez-Valero S, Galeote G, Sánchez-Recalde A, López-Fernández T, Garcia-Blas S, Iglesias D, Riera L, Moreno-Gómez I, Mesa JM, Plaza I, Ayala R, Gonzalez R, López-Sendón JL. Clinical and prognostic implications of atrial fibrillation in patients undergoing transcatheter aortic valve implantation. World J Cardiol 2012; 4(1): 8-14
- URL: https://www.wjgnet.com/1949-8462/full/v4/i1/8.htm
- DOI: https://dx.doi.org/10.4330/wjc.v4.i1.8